{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:30:43Z","timestamp":1794673843940,"version":"4.9.1"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.clineuro.2020.106059","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T14:47:50Z","timestamp":1593528470000},"page":"106059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["TTF-1 positive posterior pituitary tumor: Limitations of current treatment and potential new hope in BRAF V600E mutation variants"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6034-8242","authenticated-orcid":false,"given":"Fakhry M.","family":"Dawoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy A.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredric B.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon H.","family":"Uhm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2020.106059_bib0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11154-019-09484-1","article-title":"Primary tumors of the posterior pituitary: a systematic review","volume":"20","author":"Guerrero-P\u00e9rez","year":"2019","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.clineuro.2020.106059_bib0010","first-page":"1","article-title":"Primary papillary epithelial tumour of the sella: expanding the spectrum of TTF-1-positive sellar lesions","author":"Roncaroli","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.clineuro.2020.106059_bib0015","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.21873\/anticanres.13549","article-title":"Panniculitis under successful targeted inhibition of the MAPK\/ERK signaling pathway in a patient with BRAF V600E-mutated spindle cell oncocytoma of the pituitary gland","volume":"39","author":"Sollfrank","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.clineuro.2020.106059_bib0020","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-013-0276-z","article-title":"Targeted therapies in brain metastases","author":"Lin","year":"2014","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.clineuro.2020.106059_bib0025","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/cancers11091262","article-title":"BRAF mutations and the utility of RAF and MEK inhibitors in primary brain tumors","volume":"11","author":"Schreck","year":"2019","journal-title":"Cancers (Basel)"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720304029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720304029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:37:06Z","timestamp":1759588626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720304029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":5,"alternative-id":["S0303846720304029"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106059","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TTF-1 positive posterior pituitary tumor: Limitations of current treatment and potential new hope in BRAF V600E mutation variants","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106059"}}